Clinical Trial Update: Surfactant Application During Spontaneous Breathing With Continuous Positive Airway Pressure (CPAP) in Premature Infants < 27 Weeks [NA]

View source ↗

Summary

A completed clinical trial evaluated surfactant administration during spontaneous breathing with CPAP in extremely premature infants under 27 weeks gestation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neonatal Respiratory Distress Syndrome

Drugs mentioned

• Pulmonary surfactant

Snippet

Sponsor: University of Cologne | Conditions: Respiratory Distress Syndrome, Newborn | NA | Status: COMPLETED